FOLH1 and glioblastoma: As regards PBTs, it was shown that patients with a high/increasing level of PSMA in neovasculature in tumoral recurrence (glioblastoma multiforme) survived shorter than with low/decreasing vascular expression, so this seems to be a negative prognostic marker.